- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: DPP4 inhibitor (Linagliptin 5 MG)
Total 8150 results
-
Mylan Pharmaceuticals IncCompleted
-
Institute for the Study of Urological Diseases,...CompletedErectile Dysfunction | Low Intensity Shockwave TherapyGreece
-
Idorsia Pharmaceuticals Ltd.CompletedHealthy SubjectsNetherlands
-
Alexza Pharmaceuticals, Inc.Completed
-
Nantes University HospitalTerminated
-
PfizerCompletedDiabetes, Type 2Canada, United States, Korea, Republic of, Taiwan, Mexico, Hungary, Slovakia
-
Mansoura UniversityActive, not recruitingOveractive Bladder | Benign Prostatic HyperplasiaEgypt
-
Shanghai Zhongshan HospitalNot yet recruitingGlucocorticoid Resistant ICIs-related Myocarditis
-
Johnson & Johnson Pharmaceutical Research & Development...Eisai Inc.CompletedGastroesophageal RefluxUnited States, Belgium, Israel, Poland, Australia, Netherlands, South Africa, Hungary, Bulgaria, Denmark
-
GlaxoSmithKlineHammersmith Medicines Research; Covance HarrogateCompletedHypertension, PulmonaryUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisBristol-Myers SquibbActive, not recruitingCancer-associated ThrombosisFrance, Spain, Netherlands, Belgium, Austria, Greece, Switzerland, Canada, Italy, Poland, United Kingdom
-
PfizerCompletedAlzheimer's DiseaseUnited States
-
Menarini International Operations Luxembourg SACompleted
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Taiwan, Philippines, Australia, Hong Kong, Korea, Republic of, Canada, Italy, Malaysia, United Kingdom, Mexico, Greece, Spain, Netherlands, Switzerland, Israel, Portugal, Germany, Finland, Norway, Romania, Sweden, Serbia and more
-
Baylor College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 1 DiabetesUnited States
-
Conatus Pharmaceuticals Inc.UnknownDecompensated CirrhosisUnited States
-
Vanderbilt UniversityCompletedHypertension | Diabetes Type 2United States
-
University Hospital, GrenobleCompleted
-
Johnson & Johnson Pharmaceutical Research & Development...Completed
-
LG ChemNot yet recruitingHealthy Volunteers
-
Pusan National University HospitalCompletedErectile DysfunctionKorea, Republic of
-
Reata, a wholly owned subsidiary of BiogenAbbVie; Friedreich's Ataxia Research AllianceActive, not recruitingFriedreich AtaxiaUnited States, Australia, Austria, Italy, United Kingdom
-
United TherapeuticsWithdrawnPulmonary HypertensionUnited States, Australia, Mexico
-
Celgene CorporationICON Clinical ResearchCompletedMyelodysplastic SyndromesGermany, Israel, United Kingdom, Spain, Belgium, Italy, France, Netherlands, Sweden
-
Ardea Biosciences, Inc.Completed
-
ViiV HealthcareGlaxoSmithKlineCompletedHIV InfectionsUnited States
-
Kurume UniversityEisai Inc.; Mebix IncCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Bial - Portela C S.A.CompletedPulmonary Arterial HypertensionNetherlands
-
Pfizer's Upjohn has merged with Mylan to form Viatris...CompletedHealthy VolunteersUnited States
-
PharmaEssentiaAthenex, Inc.Completed
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Czech Republic, Finland, Greece, India, Israel, Mexico, New Zealand, Russian Federation, Sweden
-
Rabin Medical CenterUnknown
-
Alexza Pharmaceuticals, Inc.Atlanta Center for Medical ResearchCompleted
-
Fayoum UniversityBoehringer IngelheimCompletedDiabetes | Microalbuminuria | Kidney Function Affection Upon Exposure to RadiocontrastEgypt
-
Galenicum HealthCompletedType 2 Diabetes | BioequivalenceCanada
-
Galenicum HealthCompletedDiabetes Mellitus, Type 2 | BioequivalenceCanada
-
Merck Sharp & Dohme LLCTerminated
-
Strategic Science & Technologies, LLCCompleted
-
Organon and CoCompletedMigraine Disorders
-
Emory UniversityMerck Sharp & Dohme LLCTerminated
-
Seattle Gummy CompanyNot yet recruiting
-
Eisai Co., Ltd.Completed
-
Cardioangiologisches Centrum BethanienActive, not recruitingHeavy Menstrual BleedingGermany
-
University of Roma La SapienzaCompletedDiabetes Mellitus, Type 2 | Endothelial DysfunctionItaly
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, New Zealand, Spain, Japan, Finland, Germany, Greece, Romania, South Africa, Denmark, Colombia, Poland, United Kingdom, Mexico, Australia, Belgium, Ireland